By Josh White
Date: Friday 20 Jun 2025
(Sharecast News) - ValiRx confirmed on Friday that Ambrose Healthcare has exercised its option to license the VAL401 oncology asset, in a deal worth up to £16m plus royalties.
Update on Evaluation Agreement with Stingray Bio | 05-Aug-2025 | 09:53 | RNS |
Licensing Agreement with Dominion Biotech Ltd | 04-Aug-2025 | 07:00 | RNS |
Collaboration Agreement with Voxcell BioInnovation | 29-Jul-2025 | 07:00 | RNS |
Result of AGM | 30-Jun-2025 | 15:48 | RNS |
Ambrose Exercise Option on VAL401 | 20-Jun-2025 | 07:00 | RNS |
IOS acquires Indian restaurants owner | 30-Jan-2008 | Times |
Small caps | 13-Nov-2007 | Times |
Kelda springs to life as takeover talk bubbles up | 11-Sep-2007 | Telegraph |
Kelda climbs on revived takeover speculation | 11-Sep-2007 | The Independent |
Alliance & Leicester buoyed by talk of NAB bid | 09-Aug-2007 | The Independent |
No recent information was found.
Currency | UK Pounds |
Share Price | 0.60p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 2.70 |
52 Week Low | 0.42 |
Volume | 4,569,009 |
Shares Issued | 374.35m |
Market Cap | £2.25m |
RiskGrade | 435 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:26 | 261 @ 0.65p |
16:19 | 300,000 @ 0.55p |
15:49 | 10,000 @ 0.61p |
15:32 | 250,000 @ 0.56p |
15:03 | 500,000 @ 0.57p |
You are here: research